Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis
Headache The Journal of Head and Face Pain2015Vol. 55(S4), pp. 221–235
Citations Over TimeTop 1% of 2015 papers
Chris Cameron, Shannon Kelly, Shu‐Ching Hsieh, Meghan Murphy, Li Chen, Ahmed Kotb, Joan Peterson, Doug Coyle, Becky Skidmore, Tara Gomes, Tammy Clifford, George A. Wells
Abstract
Triptans are effective for migraine relief. Standard dose triptans are associated with better outcomes than ergots, and most triptans are associated with equal or better outcomes compared with NSAIDs, ASA, and acetaminophen. Use of triptans in combination with ASA or acetaminophen, or using alternative modes of administration such as injectables, may be associated with slightly better outcomes than standard dose triptan tablets.
Related Papers
- → Infrequent or Non-Response to Oral Sumatriptan does not Predict Response to Other Triptans—Review of Four Trials(2005)54 cited
- → The Experience of Combining Agents, Specially Triptans and Non Steroidal Anti-Inflammatory Drugs, for the Acute Treatment of Migraine - A Review(2007)14 cited
- → Comparative aspects of triptans in treating migraine(2001)13 cited
- [Sumatriptan plus naproxen for acute migraine attacks in adults].(2014)
- [The role of triptans and analgesics for primary headache treatment].(2005)